Hepatitis, Chronic: all 829 studies
Page 9 of 9. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive PatientsCompletedNCT00146016Phase 3
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis CCompletedNCT00144469Phase 3
- CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) SubjectsCompletedNCT00142103Phase 1
- Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)CompletedNCT00140725Phase 3
- Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
- Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
- Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard TherapyCompletedNCT00120861Phase 2
- Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis CCompletedNCT00120835Phase 1/2
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis CCompletedNCT00118768Phase 2
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaStatus unknownNCT00117533Phase 4
- Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
- Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment NaiveCompletedNCT00093093Phase 3
- Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyCompletedNCT00086541Phase 3
- CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)CompletedNCT00084279Phase 2
- Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis BCompletedNCT00071201Phase 3
- A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis BCompletedNCT00057265Phase 3
- Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis BCompletedNCT00048945Phase 3
- An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment OptionsApproved for marketingNCT00042393
- Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis BTerminatedNCT00040144Phase 2
- Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.TerminatedNCT00037622Not applicable
- A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to LamivudineCompletedNCT00036608Phase 3
- A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e AntigenCompletedNCT00035789Phase 3
- A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenCompletedNCT00035633Phase 3
- Gamma Interferon Therapy for Chronic Hepatitis CCompletedNCT00028275Phase 2
- Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
- Long-Term Therapy With Ribavirin for Chronic Hepatitis CCompletedNCT00001854Phase 4
- Combination Drug Therapy for Patients With Hepatitis CCompletedNCT00001729Phase 3
- Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 2